SEC Form 4 · accession 0001140361-15-009153
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gerald R Melillo Jr.
Officer — President, Sales Services
Period of report
Feb 24, 2015
Accepted (ET)
Feb 26, 2015 · 5:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Feb 24, 2015 | A | 91,217 | $1.85 | A | 136,948 | D | |
| Common StockF1 | holding | — | — | — | 45,731 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Appreciation RightsF3 | $6.63 | holding | — | — | — | — | Jan 30, 2017 | Common Stock | 21,478 | 21,478 | D |
| Stock Appreciation RightsF4 | $5.44 | holding | — | — | — | — | Apr 4, 2018 | Common Stock | 30,364 | 51,842 | D |
| Stock Appreciation RightsF5 | $5.13 | holding | — | — | — | — | Feb 25, 2019 | Common Stock | 57,107 | 108,949 | D |
Explanation of responses
- F1Includes 10,997 restricted shares of common stock that vest on April 4, 2016, and 20,270 restricted shares of common stock that vest on February 25, 2017.
- F2Restricted shares of common stock that vest on February 24, 2018.
- F3Exercisable.
- F4Stock appreciation rights that are one-third vested and the remaining two-thirds vest one-half on each of 4/4/15 and 4/4/16.
- F5Stock appreciation rights that are one-third vested and the remaining two-thirds vest one-half on each of 2/25/16 and 2/25/17.